The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Stem cell, Granulocyte Colony Stimulating Factor and or Dihexa to promote limb function recovery in a rat sciatic nerve damage repair model: Experimental animal studies ScienceDirect Peptide therapy finds a home in San Antonio's wellness market The Peptide Craze Ground Truths Buy Dihexa US Warehouse Cosmetic Peptides 99% Purity 5mg 10mg Vials Lyophilized Powder Pharmaceutical Grade from SYS Pharma Corp. ECHEMI